• Our Approach

Mariposa’s first programme is based on a lead compound derived from decades of chemistry and biology expertise in Neem Biotech, to extract, synthesize and develop molecules that have proven biological activity, which can be transformed into innovative drug candidates.

Patents were filed for our particular compounds targeting the Nrf2 pathway. The levels of potency seen in early tests show significantly better activity than other molecules targeting this pathway such as Sulphoraphane. 

Mariposa is now in the process of developing the programme to show positive proof-of-concept in a Phase IIa clinical trial.